Search

Keith Horspool reflects on the efforts that led the FDA to launch its pilot review program for novel excipients

How can pharma companies ensure the future success of the oligonucleotide therapeutic market?

The efforts of CDMOs have been absolutely crucial in the pandemic response. We ask five CDMO gurus how they reacted to COVID-19.

How did SiO2 quintuple their workforce and increase production capacity 12-fold in just a few months?

It’s December – time for The Medicine Maker to welcome you to 2022’s most innovative new technologies in drug development and manufacturing

Sitting Down With… Frédéric Triebel, Co-Founder, Chief Scientific Officer, and Chief Medical Officer of Immutep, France.

Ian Lichfield from WHP talks pharmaceutical cleanroom design, construction, and manufacturing trends in the industry.

How are the last few years of pharmaceutical industry trends affecting the drug delivery landscape – and what opportunities should we grasp?

Efficient data management is critical to meet the demand for fast drug development – especially in light of COVID-19

Read our roundtable discussion about a pilot program in the US for novel excipients featuring experts from IPEC-Americas.